Paller AS, Simpson EL, Siegfried EC, Cork MJ, et al. Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2022;400:908-919.
PMID: 36116481